| Jessica Wiley, BSN, RN | |
|
1132 N 198th St Unit C304, Shoreline, WA 98133-3661 | |
| (206) 429-5281 | |
| Not Available |
| Full Name | Jessica Wiley |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 1132 N 198th St Unit C304, Shoreline, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215689872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN60673694 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Wiley, BSN, RN 1132 N 198th St Unit C304, Shoreline, WA 98133-3661 Ph: (206) 429-5281 | Jessica Wiley, BSN, RN 1132 N 198th St Unit C304, Shoreline, WA 98133-3661 Ph: (206) 429-5281 |
News Archive
Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be conducted by New York State Psychiatric Institute researchers.
DiosCURE SE announced a publication in Science describing its core technology of multivalent single-chain antibodies with a unique molecular mode-of-action to inactivate SARS-CoV-2 virions. An international team led by scientists at the University of Bonn developed and characterized the lead candidates, which are exclusively licensed by DiosCURE.
The management of acute coronary syndromes (with or without ST segment elevation) requires the use of anticoagulants, antiplatelet agents (aspirin, clopidogrel and/or glycoprotein (GP) IIb/IIIa inhibitors), beta-blockers, thrombolytics in some cases, and revascularization / reperfusion.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 2 days ago
Janice Lin, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 16549 Aurora Ave N, Shoreline, WA 98133 Phone: 206-533-2600 | |
Maria Castillote, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15535 Corliss Ave N, Shoreline, WA 98133 Phone: 206-669-9782 | |
Joanne Godmintz, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1840 Ne Serpentine Pl, Shoreline, WA 98155 Phone: 206-412-0220 | |
Sara T Podczervinski, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1610 Ne 150th St, Shoreline, WA 98155 Phone: 206-418-5500 | |
Mrs. Judith Cuanan Reyes, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 16748 Corliss Ave N, Shoreline, WA 98133 Phone: 206-660-4419 Fax: 206-558-0543 | |
Katherine Gibson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1809 N 203rd St, Shoreline, WA 98133 Phone: 206-533-8761 Fax: 425-252-2807 | |
Mrs. Sylvia Isabel Roberts, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 16715 Aurora Ave N, Shoreline, WA 98133 Phone: 206-542-9766 Fax: 206-542-0326 |